Emphysema Treatment

Emphysema treatment

Emphysema Treatment Available at the Lung Institute

There is not yet a cure for emphysema, so treatment typically focuses on managing symptoms through a combination of drugs, breathing exercises and supplemental oxygen. At the Lung Institute, we offer a breakthrough alternative treatment for emphysema and other types of chronic obstructive pulmonary disease (COPD), utilizing stem cells in an effort to potentially help improve lung function.

We specialize in autologous stem cell therapy, which uses the patient’s own stem cells to stimulate the body’s natural healing processes. For many people with emphysema, this advanced therapy may help them participate in the activities they enjoy while reducing common issues associated with lung problems, such as shortness of breath, coughing and wheezing. In fact, more than 80 percent of patients with COPD report an improved quality of life after receiving stem cell therapy at the Lung Institute.

Our stem cell treatment for emphysema is performed in an outpatient clinical setting over the course of two days. Our experienced physicians harvest stem cells in one of two ways – through a simple blood draw in the arm or through a minimally invasive bone marrow extraction – depending on each patient’s unique health situation. Both of these approaches are safe and relatively painless. From there, the growth factor-rich stem cells are separated from other cells, processed in an onsite lab and intravenously returned to the patient’s body with the goal of reducing inflammation in the lungs and potentially slowing disease progression. Stem cells are a natural component of the body and not a drug, so most patients experience no adverse side effects after this form of emphysema treatment.

To take your first step toward learning if you are a candidate for emphysema treatment at the Lung Institute, contact our compassionate medical team today at (800) 729-3065. We’ll be glad to assist you in exploring alternative treatment options to help you breathe easier.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.